The WHO and why of HIV vaccine trials.

Nature ·Vol. 372 ·No. 6504 ·1994-11-24 ·Pages 313-4

Moore J, Anderson R

Abstract

A World Health Organization (WHO) advisory committee meeting in Geneva at the end of last month approved phase III trials for HIV vaccines in developing countries. What is the justification for this decision?

MeSH Terms

AIDS Vaccines Acquired Immunodeficiency Syndrome/epidemiology Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Cohort Studies Developing Countries Humans Randomized Controlled Trials as Topic World Health Organization

Chemicals

AIDS Vaccines

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Moore J

Aaron Diamond AIDS Research Center, New York, New York 10016.

Anderson R

Article Info

Journal

Nature

Abbr.

Nature

ISSN

0028-0836

DOI

10.1038/372313a0

Published

1994-11-24

Pages

313-4

Language

English

Region

England

NLM ID

0410462

Subset

Corrections

CommentOn

PMID: 7832853

External Links

PubMed source DOI: 10.1038/372313a0 View journal details

Analysis Services

The WHO and why of HIV vaccine trials.

Contact

WeChat Official Account